4.6 Article

Patient Perspectives on the Experience of Being Newly Diagnosed with HIV in the Emergency Department/Urgent Care Clinic of a Public Hospital

Journal

PLOS ONE
Volume 8, Issue 8, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0074199

Keywords

-

Funding

  1. [K23 MH092220]
  2. [R34 096606]

Ask authors/readers for more resources

We sought to understand patient perceptions of the emergency department/urgent care (ED/UC) HIV diagnosis experience as well as factors that may promote or discourage linkage to HIV care. We conducted in-depth interviews with patients (n=24) whose HIV infection was diagnosed in the ED/UC of a public hospital in San Francisco at least six months prior and who linked to HIV care at the hospital HIV clinic. Key diagnosis experience themes included physical discomfort and limited functionality, presence of comorbid diagnoses, a wide spectrum of HIV risk perception, and feelings of isolation and anxiety. Patients diagnosed with HIV in the ED/UC may not have their desired emotional supports with them, either because they are alone or they are with family members or friends to whom they do not want to immediately disclose. Other patients may have no one they can rely on for immediate support. Nearly all participants described compassionate disclosure of test results by ED/UC providers, although several noted logistical issues that complicated the disclosure experience. Key linkage to care themes included the importance of continuity between the testing site and HIV care, hospital admission as an opportunity for support and HIV education, and thoughtful matching by linkage staff to a primary care provider. ED/UC clinicians and testing programs should be sensitive to the unique roles of sickness, risk perception, and isolation in the ED/UC diagnosis experience, as these things may delay acceptance of HIV diagnosis. The disclosure and linkage to care experience is crucial in forming patient attitudes towards HIV and HIV care, thus staff involved in disclosure and linkage activities should be trained to deliver compassionate, informed, and thoughtful care that bridges HIV testing and treatment sites.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor response

Xinghuo Li, Anthony F. Daniyan, Andrea V. Lopez, Terence J. Purdon, Renier J. Brentjens

Summary: CAR T-cell therapy has shown significant efficacy in B-cell malignancies, but the lack of persistence and immune escape present challenges. By secreting IL-36 gamma, CAR T cells demonstrated improved expansion and persistence, resulting in enhanced tumor eradication. IL-36 gamma also activated endogenous APCs and T cells, delaying the progression of antigen-negative tumors. These findings support the translation of this design for a more effective CAR T-cell-mediated antitumor response.

LEUKEMIA (2021)

Article Oncology

Optimization of T-cell Receptor-Modified T Cells for Cancer Therapy

Dylan J. Drakes, Sarwish Rafiq, Terence J. Purdon, Andrea V. Lopez, Smita S. Chandran, Christopher A. Klebanoff, Renier J. Brentjens

CANCER IMMUNOLOGY RESEARCH (2020)

Article Multidisciplinary Sciences

CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function

Nicholas F. Kuhn, Andrea V. Lopez, Xinghuo Li, Winson Cai, Anthony F. Daniyan, Renier J. Brentjens

NATURE COMMUNICATIONS (2020)

Article Dermatology

Detection of bacterial fluorescence from in vivo wound biofilms using a point-of-care fluorescence imaging device

Andrea J. Lopez, Laura M. Jones, Landrye Reynolds, Rachel C. Diaz, Isaiah K. George, William Little, Derek Fleming, Anna D'souza, Monique Y. Rennie, Kendra P. Rumbaugh, Allie Clinton Smith

Summary: This study demonstrated the detection of porphyrin-producing bacteria within biofilms using bacterial fluorescence imaging in vivo, with red fluorescence readily detectable in wounds 48 hours after inoculation. The findings highlight the potential importance of this technology in biofilm research and early detection in clinical settings.

INTERNATIONAL WOUND JOURNAL (2021)

Article Oncology

ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine

Nora E. Rahmani, Nandini Ramachandra, Srabani Sahu, Nadege Gitego, Andrea Lopez, Kith Pradhan, Tushar D. Bhagat, Shanisha Gordon-Mitchell, Bianca Rivera Pena, Mohammad Kazemi, Keshav Rao, Orsi Giricz, Shahina Bano Maqbool, Raul Olea, Yongmei Zhao, Jinghang Zhang, Hamid Dolatshad, Vickram Tittrea, Dharamveer Tatwavedi, Shalini Singh, Juseong Lee, Tianyu Sun, Ulrich Steidl, Aditi Shastri, Daichi Inoue, Omar Abdel-Wahab, Andrea Pellagatti, Evripidis Gavathiotis, Jacqueline Boultwood, Amit Verma

Summary: The study suggests that leukemia cells with ASXL1 mutations are more sensitive to Venetoclax and Azacytidine, possibly due to the upregulation of BCL2 expression and DNA methylation changes caused by ASXL1 mutations. These results reveal the potential effectiveness of these therapeutic drugs for leukemia patients.

BLOOD CANCER JOURNAL (2021)

Article Engineering, Biomedical

Combination product of dermal matrix, preconditioned human mesenchymal stem cells and timolol promotes wound healing in the porcine wound model

Hsin-ya Yang, Fernando Fierro, Daniel J. Yoon, Anthony Gallegos, Stephanie L. Osborn, Alan Nguyen, Thomas R. Peavy, William Ferrier, Linda Talken, Betty W. Ma, Kristopher G. Galang, Andrea Medina Lopez, Daniel R. Fregoso, Heather Stewart, Eric A. Kurzrock, Athena M. Soulika, Jan A. Nolta, R. Rivkah Isseroff

Summary: A combination treatment involving human mesenchymal stem/stromal cells (MSCs) embedded in an extracellular matrix scaffold and preconditioned with hypoxia and the beta-adrenergic receptor antagonist timolol, combined with sustained application of timolol post implantation, has shown promising results for improving wound healing in a diabetic mouse model. This study extends those findings to a porcine wound model, further demonstrating the efficacy and safety of the combined treatment in promoting wound reepithelialization and angiogenesis while maintaining a safe concentration of timolol in the plasma.

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2022)

Article Public, Environmental & Occupational Health

Understanding Racial Inequities in the Implementation of Harm Reduction Initiatives

Andrea M. Lopez, Matthew Thomann, Zena Dhatt, Julieta Ferrera, Marwa Al-Nassir, Margaret Ambrose, Shane Sullivan

Summary: This study aims to elucidate a structurally oriented theoretical framework that considers legacies of racism, trauma, and social exclusion, and to interrogate the unmet obligations of the harm reduction infrastructure in providing equitable protections to Black and Latinx people who use drugs in Maryland. The research found that the unmet obligations included enforcement and punitive governance of drug use equipment, racism and social exclusion, and differential implications of harm reduction for different populations experiencing racialized criminalization.

AMERICAN JOURNAL OF PUBLIC HEALTH (2022)

Article Multidisciplinary Sciences

Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer

Andrea Lopez, Denis E. Reyna, Nadege Gitego, Felix Kopp, Hua Zhou, Miguel A. Miranda-Roman, Lars Ulrik Nordstrom, Swathi-Rao Narayanagari, Ping Chi, Eduardo Vilar, Aristotelis Tsirigos, Evripidis Gavathiotis

Summary: Deregulation of the BCL-2 family interaction network is a major challenge in cancer treatment. This study presents a novel therapeutic strategy to overcome two anti-apoptotic mechanisms in cancer through the combination of a BAX activator and Navitoclax.

NATURE COMMUNICATIONS (2022)

Article Economics

Limitations of standard cost-effectiveness methods for health technology assessment of treatments for rare, chronic diseases: a case study of treatment for cystic fibrosis

Jaime L. Rubin, Andrea Lopez, Jason Booth, Penilla Gunther, Anupam B. Jena

Summary: This study examines the impact of modifications to standard cost-effectiveness analysis methods on measures of cost-effectiveness for rare chronic diseases, finding that modifying assumptions for discounting rates, utility measures, disease management costs, and drug pricing can significantly reduce the incremental cost-effectiveness ratio.

JOURNAL OF MEDICAL ECONOMICS (2022)

Article Hospitality, Leisure, Sport & Tourism

Not so rebel after all: Profiling personality traits in mountain running athletes

Andrea Lopez, Raimundo Sanchez

Summary: This study examined the personality traits of trail runners in a competition in Chile using the NEO-FFI questionnaire. The results showed that successful mountain runners exhibited high Conscientiousness and low Neuroticism, but there were no significant differences in Openness to Experience compared to the normal population. There were also no significant differences in traits between ultradistance and shorter distance runners, or based on motivations and gender (except for Agreeableness). The findings have practical implications for sports practitioners in designing interventions based on athletes' personality profiles and challenging gender stereotypes in sports.

RETOS-NUEVAS TENDENCIAS EN EDUCACION FISICA DEPORTE Y RECREACION (2023)

Correction Public, Environmental & Occupational Health

Understanding Racial Inequities in the Implementation of Harm Reduction Initiatives (vol 112, pg 173, 2022)

Andrea M. Lopez, Matthew Thomann, Zena Dhatt, Julieta Ferrera, Marwa Al-Nassir, Maggie Ambrose, Shane Sullivan

AMERICAN JOURNAL OF PUBLIC HEALTH (2022)

Meeting Abstract Respiratory System

Risk factors associated with dinapenia in subjects recovered from COVID-19

Andrea Samantha Hernandez Lopez, Arturo Orea Tejeda, Dulce Gonzalez Islas, Susana Galicia Amor, Esperanza Trejo Mellado, Juan Carlos Garcia Hernandez, Maria Fernanda Salgado Fernandez, Carlos Miguel Sanchez Moreno

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Substance Abuse

Co-use of methamphetamine and opioids among people in treatment in Oregon: A qualitative examination of interrelated structural, community, and individual-level factors

Andrea M. Lopez, Zena Dhatt, Mary Howe, Marwa Al-Nassir, Amy Billing, Eleanor Artigiani, Eric D. Wish

Summary: The study in the United States found that rates of methamphetamine use and methamphetamine-related deaths have been increasing, with methamphetamine increasingly present in opioid-related deaths. The research indicated that individuals testing positive for methamphetamine were on average five years younger than those testing negative, and nonfentanyl opioids were more common in methamphetamine positive specimens. This study suggests a need for further understanding of the co-use of methamphetamine and opioids in the context of larger socio-structural and community factors.

INTERNATIONAL JOURNAL OF DRUG POLICY (2021)

Article Oncology

A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy

Dulguun Amgalan, Thomas P. Garner, Ryan Pekson, Xiaotong F. Jia, Mounica Yanamandala, Victor Paulino, Felix G. Liang, J. Jose Corbalan, Jaehoon Lee, Yun Chen, George S. Karagiannis, Luis Rivera Sanchez, Huizhi Liang, Swathi-Rao Narayanagari, Kelly Mitchell, Andrea Lopez, Victoria Margulets, Marco Scarlata, Gaetano Santulli, Aarti Asnani, Randall T. Peterson, Rachel B. Hazan, John S. Condeelis, Maja H. Oktay, Ulrich Steidl, Lorrie A. Kirshenbaum, Evripidis Gavathiotis, Richard N. Kitsis

NATURE CANCER (2020)

No Data Available